As of 5 Jul 2026, Ami Organics share price is ₹3,694.80. The stock opened at ₹3,709.00, compared to its previous close of ₹3,691.80. During today's trading session, Ami Organics share price moved in the range of ₹3,656.10 to ₹3,730.90, with an average price of ₹3,693.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,095.40 and a high of ₹3,730.90. On the performance front, Ami Organics share price has increased by 111.22% over the last six months and is up 235.68% on a year-on-year basis.
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1,006.88 | ₹717.47 | ₹616.73 | ₹520.14 |
| Other Income | ₹16.93 | ₹7.49 | ₹4.32 | ₹2.76 |
| Total Revenue | ₹1,023.80 | ₹724.97 | ₹621.05 | ₹522.90 |
| Total Expenses | ₹807.64 | ₹610.98 | ₹508.88 | ₹431.45 |
| Profit Before Tax | ₹216.16 | ₹81.90 | ₹112.17 | ₹91.45 |
| Tax | ₹55.75 | ₹33.19 | ₹28.88 | ₹19.50 |
| Profit After Tax | ₹160.42 | ₹48.71 | ₹83.29 | ₹71.95 |
| EPS - Basic | ₹19.91 | ₹5.96 | ₹22.86 | ₹21.03 |
| EPS - Diluted | ₹19.91 | ₹5.95 | ₹22.86 | ₹21.03 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹216.16 | ₹81.90 | ₹112.17 | ₹91.45 |
| Income before WC changes | ₹235.09 | ₹131.69 | ₹126.27 | ₹105.09 |
| Change in Assets | -₹101.04 | -₹32.51 | -₹67.33 | -₹118.29 |
| Change in Liabilities | ₹31.03 | ₹50.33 | ₹31.05 | ₹24.07 |
| Change in WC | -₹70.01 | ₹17.82 | -₹36.28 | -₹94.21 |
| Cash flow from Operations | ₹118.34 | ₹125.17 | ₹65.53 | -₹11.93 |
| Cash flow from Investing | -₹223.94 | -₹365.39 | -₹33.04 | -₹120.72 |
| Cash flow from Financing | ₹261.12 | ₹239.36 | -₹12.25 | ₹140.26 |
| Total Cash Flow | ₹155.52 | -₹0.86 | ₹20.24 | ₹7.61 |
| Cash (Start of the year) | ₹29.70 | ₹30.53 | ₹10.30 | ₹2.68 |
| Cash (End of the year) | ₹185.22 | ₹29.70 | ₹30.53 | ₹10.30 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹757.63 | ₹602.60 | ₹309.81 | ₹229.31 |
| Current Assets | ₹791.64 | ₹493.30 | ₹457.13 | ₹429.57 |
| Total Assets | ₹1,549.26 | ₹1,095.90 | ₹766.94 | ₹658.88 |
| Current Liabilities | ₹202.25 | ₹285.17 | ₹162.85 | ₹129.32 |
| Net Current Asset | ₹589.39 | ₹208.13 | ₹294.28 | ₹300.25 |
| Non-Current Liabilities | ₹26.93 | ₹127.98 | ₹10.13 | ₹7.29 |
| Equity Capital | ₹1,320.08 | ₹682.76 | ₹593.96 | ₹522.27 |
| Total Equity & Liabilities | ₹1,549.26 | ₹1,095.90 | ₹766.94 | ₹658.88 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹989.83 | ₹687.58 | ₹616.73 | ₹520.14 |
| Other Income | ₹18.34 | ₹13.79 | ₹4.32 | ₹2.76 |
| Total Revenue | ₹1,008.17 | ₹701.37 | ₹621.05 | ₹522.90 |
| Total Expenses | ₹794.59 | ₹600.51 | ₹508.83 | ₹431.45 |
| Profit Before Tax | ₹213.58 | ₹69.11 | ₹112.22 | ₹91.45 |
| Tax | ₹54.03 | ₹25.42 | ₹28.88 | ₹19.50 |
| Profit After Tax | ₹159.55 | ₹43.68 | ₹83.34 | ₹71.95 |
| EPS - Basic | ₹19.91 | ₹5.96 | ₹22.87 | ₹21.03 |
| EPS - Diluted | ₹19.91 | ₹5.95 | ₹22.87 | ₹21.03 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹213.58 | ₹69.11 | ₹112.22 | ₹91.45 |
| Income before WC changes | ₹228.18 | ₹110.95 | ₹123.42 | ₹103.81 |
| Change in Assets | -₹101.28 | -₹41.79 | -₹73.65 | -₹114.75 |
| Change in Liabilities | ₹32.74 | ₹47.81 | ₹30.42 | ₹24.07 |
| Change in WC | -₹68.54 | ₹6.02 | -₹43.23 | -₹90.68 |
| Cash flow from Operations | ₹115.93 | ₹100.85 | ₹55.73 | -₹9.69 |
| Cash flow from Investing | -₹234.37 | -₹337.35 | -₹20.47 | -₹122.47 |
| Cash flow from Financing | ₹273.56 | ₹235.48 | -₹14.44 | ₹140.26 |
| Total Cash Flow | ₹155.12 | -₹1.02 | ₹20.82 | ₹8.10 |
| Cash (Start of the year) | ₹29.49 | ₹30.48 | ₹9.66 | ₹1.56 |
| Cash (End of the year) | ₹184.61 | ₹29.49 | ₹30.48 | ₹9.66 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹766.64 | ₹603.44 | ₹304.75 | ₹227.90 |
| Current Assets | ₹771.31 | ₹467.81 | ₹454.71 | ₹426.71 |
| Total Assets | ₹1,537.95 | ₹1,071.25 | ₹759.46 | ₹654.61 |
| Current Liabilities | ₹199.04 | ₹267.84 | ₹162.78 | ₹129.31 |
| Net Current Asset | ₹572.27 | ₹199.97 | ₹291.93 | ₹297.39 |
| Non-Current Liabilities | ₹27.32 | ₹128.29 | ₹9.89 | ₹7.29 |
| Equity Capital | ₹1,311.60 | ₹675.12 | ₹586.79 | ₹518.00 |
| Total Equity & Liabilities | ₹1,537.95 | ₹1,071.25 | ₹759.46 | ₹654.61 |
Acutaas Chemicals Limited, formerly Ami Organics Limited, is a manufacturer of pharma intermediates and specialty chemicals. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. It manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It has developed and commercialized over 520 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas since inception and NCE across select high-growth high margin chronic therapeutic areas.
Ami Organics share price is ₹3,694.80 as on 03 Jul, 2026, 15:57 IST.
In the last 1 year, Ami Organics delivered a return of 235.68%. The Ami Organics share price hit a high of ₹3,730.90 and low of ₹1,095.40.
The Mutual Fund Shareholding in Ami Organics was 13.86% at the end of Mar 2026.
The 52-week high and low of Ami Organics share is ₹3,730.90 and ₹1,095.40 as of 03 Jul, 2026.
The market capitalisation of Ami Organics is ₹30,211.70 Crores as on 03 Jul, 2026.
The stock symbol of Ami Organics is ACUTAAS on the NSE, 543349 on the BSE, and the ISIN is INE00FF01025.
Ami Organics shares closed yesterday at ₹3,691.80 on NSE & ₹3,690.15 on BSE
To buy Ami Organics shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
No, shares of Ami Organics or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Ami Organics shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
The PE and PB ratio of Ami Organics is 84.77 and 18.27 respectively, as on 03 Jul, 2026, 15:57 IST.